Study of a Modified Citrate Anticoagulation Protocol Using Continuous Renal Replacement Therapy in Adults with Acute Kidney Injury in the ICU
Led by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Updated on 2026-04-07
43
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate a modified continuous renal replacement therapy CRRT protocol in adult patients with acute kidney injury AKI admitted to the intensive care unit ICU. The study focuses on whether using continuous venovenous hemodiafiltration CVVHDF with post-filter replacement under regional citrate anticoagulation can better maintain electrolyte balance and reduce the need for electrolyte supplements compared to the standard continuous venovenous hemodialysis CVVHD treatment. This non-randomized interventional study compares a prospective group receiving the modified protocol with a historical control group treated with standard CRRT.
Participants in the historical group received CVVHD with regional citrate anticoagulation between 2019 and 2021, while the prospective group will receive CVVHDF with post-filter replacement starting from November 2024. Both treatments involve continuous renal replacement therapy under regional citrate anticoagulation, but differ in their modality and replacement technique. The study duration for each participant corresponds to the time they require CRRT, with data collected until CRRT is stopped.
During the study, researchers will monitor total electrolyte supplementation from CRRT start until discontinuation, up to 14 days. They will also assess the lifespan of each CRRT circuit up to 7 days. Data collection ceases once CRRT ends. The study includes adult ICU patients diagnosed with AKI who require CRRT and use regional citrate anticoagulation. The study is sponsored by Fundaci Institut de Recerca de lHospital de la Santa Creu i Sant Pau.
CONDITIONS
Brief Title
Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy
Research Team
A
Ana Jiménez Valenzuela, Nurse
A
Alejandra Espinosa Guerrero, Clinical Operations Head
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Use of regional citrate anticoagulation during CRRT
You will not qualify if you...
Known allergy or intolerance to citrate
Contraindications to citrate anticoagulation such as severe liver failure or severe metabolic disorders affecting citrate metabolism
Pregnancy or breastfeeding
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 14 days or until CRRT discontinuation
Participants receive continuous renal replacement therapy (CRRT) with regional citrate anticoagulation using either continuous venovenous hemodialysis (CVVHD) or continuous venovenous hemodiafiltration (CVVHDF) with post-filter replacement depending on group assignment.
Continuous treatment during ICU stay requiring CRRT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
A Phase 2 Double-Blind Study Comparing Kidney Protection of Cilastatin Versus Thiosulfate
in Women Undergoing Debulking Surgery with Heated Intraperitoneal Cisplatin Chemotherapy
Study to Validate and Develop the Multifactorial Dynamic Perfusion Index MDPI for Predicting Kidney Injury and Other Complications After Cardiac Surgery with Cardiopulmonary Bypass in Adults and Infants
COPE-AKI Trial Evaluating a Team-Based Care Approach for Patients After Acute Kidney Injury to Improve Hospital-Free Days and Kidney Outcomes
Comparing Kidney Injury Risks of Vancomycin with Piperacillin-Tazobactam Versus Vancomycin with Cefepime in Hospitalized Adults
Study of Early Restart Versus Usual Care of Renin-Angiotensin System Inhibitors After Acute Kidney Injury in Hospitalized Adults
Improving Care for Children Ages 1 to 18 with Acute Kidney Injury Using a Mobile Health Educational Tool
Evaluating PrismaLung Device for Carbon Dioxide Removal in Critically Ill Patients on Mechanical Ventilation A Randomized Controlled Trial
Evaluating AZD4144 for Adults with Sepsis-associated Acute Kidney Injury A Randomized, Double-blind, Placebo-controlled Phase IIa Study
Early Versus Standard Continuous Renal Replacement Therapy for Adults With Cardiogenic Shock on Veno-arterial ECMO and Acute Kidney Injury
Evaluating a Team-Based Kidney Care Program After Hospital Discharge for Adults with Moderate to Severe Acute Kidney Injury
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring.
Francesca Di Mario, Giuseppe Regolisti, Paolo Greco...
Elimination Rates of Electrolytes, Vitamins, and Trace Elements during Continuous Renal Replacement Therapy with Citrate Continuous Veno-Venous Hemodialysis: Influence of Filter Lifetime.
Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
Santo Morabito, Valentina Pistolesi, Luigi Tritapepe...
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Alexander Zarbock, Mira Küllmar, Detlef Kindgen-Milles...
Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution.
Yuen Henry Jeffrey, Shum Hoi-Ping, Anne Leung Kit Hung...